| Value | ₹12.00 Cr |
|---|
BSE filing, NSE: LGBFORGE. Summary written from the filing by ALFA Finder's alert engine.
LGB Forge Ltd: key numbers
- Share price
- ₹4.88
- Market cap
- ₹116.2 Cr
- Revenue (annual)
- ₹103.2 Cr
- Net profit (annual)
- ₹-2.22 Cr
- P/E (TTM)
- 16.1×Sector 52.6×
- Promoter holding
- 70.60%-0.21% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LGB Forge Ltd
All →LGB Forge Board Meeting Date
LGB Forge Board meeting is scheduled for 11 Nov 2026 to approve Q2/H1 FY27 standalone results. Trading window remains closed until 48 hours post-results declaration.
LGB Forge Other Announcement
LGB Forge Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
LGB Forge Annual General Meeting
LGB Forge Ltd announced the successful passage of resolutions via postal ballot, including director appointment and alterations to the Memorandum and Articles of Association.
LGB Forge Annual General Meeting
LGB Forge Limited conducted its 20th Annual General Meeting on August 14, 2026, through video conferencing. Shareholders reviewed company performance and addressed the scheduled agenda items.
LGB Forge Management Change
LGB Forge Limited has appointed Mr. Arjun Parthasarathy as a Non-Executive Non-Independent Director for a 36-month term, effective August 11, 2026.
LGB Forge Q1 FY27 Results: Net Profit ₹10.3 Cr, Up 1044.4% YoY
LGB Forge Ltd reported revenue from operations of ₹28.1 Cr (+1.8% YoY) and net profit of ₹10.3 Cr (+1044.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹10.3 Cr · +1044.4% YoY
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr